(Q42242795)

19 October 2017

title

Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells (English)

1 reference

19 October 2017

1 reference

1 reference

hepatocellular carcinoma

1 reference

Y-H Xun

1

1 reference

19 October 2017

Y-J Zhang

2

1 reference

19 October 2017

Q-C Pan

3

1 reference

19 October 2017

R-C Mao

4

1 reference

19 October 2017

Y-L Qin

5

1 reference

19 October 2017

H-Y Liu

6

1 reference

19 October 2017

Y-M Zhang

7

1 reference

19 October 2017

Y-S Yu

8

1 reference

19 October 2017

Z-H Tang

9

1 reference

19 October 2017

M-J Lu

10

1 reference

19 October 2017

G-Q Zang

11

1 reference

19 October 2017

J-M Zhang

12

1 reference

19 October 2017

publication date

24 October 2013

1 reference

Journal of Viral Hepatitis

19 October 2017

published in

1 reference

19 October 2017

volume

21

1 reference

19 October 2017

issue

8

1 reference

19 October 2017

page(s)

597-603

1 reference

Hepatitis B Virus Infection

19 October 2017

cites work

1 reference

Drug targets in hepatitis B virus infection.

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Morphogenesis of hepatitis B virus and its subviral envelope particles

21 January 2018

1 reference

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

21 January 2018

1 reference

Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus

21 January 2018

1 reference

Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection

21 January 2018

1 reference

A Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen Secretion

21 January 2018

1 reference

Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.

21 January 2018

1 reference

21 January 2018

New uses for old drugs

1 reference

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

Clinical Pharmacokinetics of Metformin

21 January 2018

1 reference

Cellular and molecular mechanisms of metformin: an overview

21 January 2018

1 reference

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

21 January 2018

1 reference

Metformin prevents endotoxin-induced liver injury after partial hepatectomy

21 January 2018

1 reference

The role of metformin in the management of NAFLD

21 January 2018

1 reference

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

21 January 2018

1 reference

AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300.

21 January 2018

1 reference

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

21 January 2018

1 reference

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

Control of hepatitis B virus at the level of transcription.

21 January 2018

1 reference

Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression

21 January 2018

1 reference

Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.

21 January 2018

1 reference

Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro

21 January 2018

1 reference

Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells

21 January 2018

1 reference

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.

21 January 2018

1 reference

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Are novel combination therapies needed for chronic hepatitis B?

21 January 2018

1 reference

Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen

21 January 2018

1 reference

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

21 January 2018

1 reference

21 January 2018

1 reference

Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication

21 January 2018

1 reference

Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB.

21 January 2018

1 reference

Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12187

1 reference

19 October 2017

1 reference